RxDoctor Payments Data

Wesam Frandah, MD

Gastroenterology · Huntington, WVNPI 1457589426

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Endogastric Solutions, Inc at 42.7% of the total. Reporting peaked in 2022 at $9,458 and has fallen 95.4% since, to $434 in 2025. Among gastroenterology clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,328in general payments, 2019–2025

Across 229 payments — averaging $123.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endogastric Solutions, Inc$12K
  • Olympus America Inc.$5K
  • Boston Scientific$3K
  • Merit Medical Systems Inc$2K
  • Olympus Corporation Of The Americas$2K
  • AbbVie$2K
  • plus $1K from 18 others

What the payments were for

  • Consulting fees$15,99456%
  • Speaking & faculty fees$1,9137%
  • Travel & lodging$4,72117%
  • Food & beverage$5,70120%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,328 in reported general payments places this provider in the 90th percentile of 72 gastroenterology providers in West Virginia.

See all gastroenterology providers in West Virginia

Medicare billing

Part B allowed, 2024
$209,816
Medicare patients
566
Services billed
1,373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RinvoqUpadacitinib13$78,589
CreonLipase/Protease/Amylase19$25,203
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl277$5,255
Dexlansoprazole DrDexlansoprazole17$4,783
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl99$2,048
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates11$935
Pantoprazole Sodium76$761
Esomeprazole Magnesium19$513
Gabapentin19$207
Omeprazole23$166
Metronidazole16$136
Levofloxacin14$24

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq, Creon$1,850$103,79232 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 72 gastroenterology providers in West Virginia.

Other gastroenterology in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →